<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03330392</url>
  </required_header>
  <id_info>
    <org_study_id>CTCF2_2017_AGP</org_study_id>
    <nct_id>NCT03330392</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy and Safety of AGP on Immune Enhancement</brief_title>
  <official_title>An 8 Week, Randomized, Double-blind, Placebo-controlled Clinical Trial of AGP on Immune Enhancing Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers investigated the immune enhancing effects of AGP for Korean participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to investigate the effects of AGP on immune enhancement based on 8
      week, randomized, double-blind, placebo-controlled clinical trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">October 27, 2017</completion_date>
  <primary_completion_date type="Actual">September 7, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Natural killer cell activity</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of NK cell activity were assessed before and after the intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interleukin-1β</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of IL-1β were assessed before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of IL-6 were assessed before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-12 (IL-12)</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of IL-12 were assessed before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interferon-γ (IFN-γ)</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of IFN-γ were assessed before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor necrosis factor-α (TNF-α)</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of TNF-α were assessed before and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of White blood cell (WBC)</measure>
    <time_frame>0 week, 8 week</time_frame>
    <description>Changes of WBC were assessed before and after the intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Immune Function</condition>
  <arm_group>
    <arm_group_label>AGP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>take two tablets per day (500 mg/day) for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>take two tablets per day for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AGP</intervention_name>
    <description>take two tablets per day (500 mg/day) for 8 weeks</description>
    <arm_group_label>AGP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>take two tablets per day (500 mg/day) for 8 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The levels of white blood cells within range 3x10^3/μL~8x10^3/μL

          -  have had at least two cold in the last 12 months.

        Exclusion Criteria:

          -  subjects with BMI&lt;18.5 kg/m^2

          -  subjects taking medications such as immune related drug or functional foods

          -  history of disease that could interfere with the test products or impede their
             absorption

          -  pregnant or lactating women and heavy smokers.

          -  being judged by the responsible physician of the local study center as unfit to
             participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Trial Center for Functional Foods Chonbuk National University Hospital</name>
      <address>
        <city>Jeonju</city>
        <state>Jeollabuk-do</state>
        <zip>54907</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Soo-Wan Chae</investigator_full_name>
    <investigator_title>Principal Investigator, Clinical Trial Center for Functional Foods</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

